Bold Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 4

Forward Citations = 7

Loading Chart...

5 inventors (with patents filed for the assignee):

Kevin N Sill (4 out of 49 patents)

Tomas Vojkovsky (4 out of 11 patents)

Adam Carie (4 out of 10 patents)

4. Suzanne Bakewell (2 out of 2 patents)

5. Jyothi Sethuraman (2 out of 2 patents)

6. Hooshmand Sheshbaradaran (6 patents)

6 patents: Sort by Forward Citations

1. 12415825 - Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof (2025-09-16),

2. 11739111 - Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof (2023-08-29),

3. 11633380 - Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer (2023-04-25),

4. 11040993 - Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof (2021-06-22),

5. 10821095 - Use of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] for the treatment of cancer (2020-11-03),

6. 10611787 - Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof (2020-04-07),

Company Overview

Bold Therapeutics is a biopharmaceutical company focused on developing innovative cancer therapies. Our lead product candidate, BOLD-100, is a first-in-class anti-resistance compound that has shown promising results in preclinical studies. With a dedicated team of scientists and researchers, we are committed to advancing therapeutics that address unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

6 Patents

#152 in Vancouver

#2,424 in Canada

Vancouver, Canada

Bold Therapeutics, Inc.

Forward Citations = 7

5 inventors:

Kevin N Sill (4 out of 49 patents)

Tomas Vojkovsky (4 out of 11 patents)

Adam Carie (4 out of 10 patents)

4. Suzanne Bakewell (2 out of 2 patents)

5. Jyothi Sethuraman (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bold Therapeutics, Inc.. Retrieved from https://idiyas.com/company/bold-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]